A Phase I/II study evaluating escalating doses of recombinant human albumin-interferon-α fusion protein in chronic hepatitis C patients who have failed previous interferon-α-based therapy

Vijayan Balan, David R. Nelson, Mark S. Sulkowski, Gregory T. Everson, Louis R. Lambiase, Rusell H. Wiesner, Rolland C. Dickson, Anthony B. Post, Robert R. Redfield, Gary L. Davis, Avidan U. Neumann, Blaire L. Osborn, William W. Freimuth, G. Mani Subramanian

Research output: Contribution to journal › Article › peer-review

63 Scopus citations

Fingerprint

Dive into the research topics of 'A Phase I/II study evaluating escalating doses of recombinant human albumin-interferon-α fusion protein in chronic hepatitis C patients who have failed previous interferon-α-based therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences